GLP-1based therapies, already recommended in adults, are gaining traction in younger populations due to their glucose-lowering and weight-reducing effects
investigated the peptides influence on neurogenic differentiation markers in human gingival mesenchymal stem cells (hGMSCs) a model system for studying neural lineage specification (9)
The New England Journal of Medicine, 384 (18), 17191730
IGF-1 complements this by promoting the repair and regeneration of blood vessels, improving overall vascular health
With the recent popularity of glucagon-like peptide-1 (GLP-1) receptor agonists for treating type 2 diabetes and weight loss, scientists are examining the treatment possibilities of this class of medications for other conditions
In the landmark LEADER trial , liraglutide was shown to reduce the risk of major cardiovascular events including heart attack, stroke, and cardiovascular death in people with type 2 diabetes at high cardiovascular risk